nimodipine has been researched along with Blood Loss, Postoperative in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hynynen, M | 1 |
| Kuitunen, A | 1 |
| Salmenpera, M | 1 |
| Manrique, R | 1 |
| Pavanello, R | 1 |
| Magalhaes, H | 1 |
2 trials available for nimodipine and Blood Loss, Postoperative
| Article | Year |
|---|---|
Surgical bleeding and calcium antagonists.
Topics: Calcium Channel Blockers; Heart Valve Prosthesis; Humans; Nimodipine; Postoperative Hemorrhage; Pros | 1996 |
Is nimodipine in cardiac surgery really so bad?
Topics: Aged; Calcium Channel Blockers; Double-Blind Method; Humans; Myocardial Revascularization; Nimodipin | 1997 |